Search the Newsreel

Strength Seen in Genius Sports Limited (GENI): Can Its 12.2% Jump Turn into More Strength?

Genius Sports Limited GENI shares rallied 12.2% in the last trading session to close at $7.27. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.5% gain …

Macrogenics Market Sentiment

This article analyzes market sentiment for MacroGenics (MGNX) through analyst consensus, short interest, options flow, and recent insider activity. It highlights a "Buy" consensus from 14 analysts with an average price target of $8, significant short interest of 9.3%, and bullish options flow. The …

Genius Sports (NYSE:GENI) Upgraded at The Goldman Sachs Group

Genius Sports (NYSE:GENI) received an upgrade to "strong-buy" from The Goldman Sachs Group, while analysts overall maintain a "Moderate Buy" consensus with an average price target of $11.19. Despite a reported quarterly loss of $0.21 per share, the company's revenue increased by 30.5% year-over-year …

Genius Sports schedules Q2 results webcast and Q&A for Aug. 6

Soligenix Inc (SNGX) Cash Flow

This article provides a detailed cash flow statement for Soligenix Inc (SNGX), covering quarterly and annual data for operating, investing, and financing activities. It presents historical financial figures and year-over-year changes across various cash flow components. The article also includes a FAQ section explaining …

GENI|Genius Sports Ltd|Price:7.230|Chg%:-0.040

This article provides a comprehensive stock analysis of Genius Sports Ltd (GENI), noting its relatively healthy fundamentals, high growth potential, and a "Buy" rating from multiple analysts with a target price of $10.32. While the stock is considered fairly valued and institutional ownership is …

Genius Sports (GENI) Jumps 12% on ‘Buy’ Call, Price Target Hike

Genius Sports (GENI) saw its stock jump over 12% following a "Buy" rating and price target hike from Goldman Sachs, which highlighted the company's potential for mid-teens annual revenue growth due to strong tailwinds in online sports betting. Other analysts, Stifel and Wells Fargo, …

Genius Sports Ltd (GENI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Genius Sports Ltd (GENI), listing major individual and institutional holders, their proportions, and recent changes in holdings. It also categorizes shareholders by type (e.g., Investment Advisor, Hedge Fund) and provides a history of institutional shareholdings over several …

Genius Sports (NYSE:GENI) Trading Up 10.2% - Time to Buy?

Genius Sports (NYSE:GENI) stock surged 10.2% to $7.14 in mid-day trading but with significantly lowered volume. Despite missing EPS estimates, the company's revenue increased by 30.5% year-over-year, and it maintains a "Moderate Buy" consensus rating from analysts with an average target price of $11.19. …

Soligenix Inc (SNGX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the major shareholders and institutional holdings of Soligenix Inc (SNGX). It lists key shareholders, their proportion of shares, and categorizes shareholder types. The report also provides quarterly institutional shareholding data and recent shareholder activity with changes in holdings for various entities.

MacroGenics, Inc. Revenue Breakdown – NASDAQ:MGNX

MacroGenics, Inc. (NASDAQ: MGNX) generated $149.50 million USD in revenue last year. The majority of this revenue, $87.18 million USD, came from its Collaborative and Other Agreements segment. The United States was the largest geographical contributor, accounting for the entire $149.50 million USD of …

Citizens reiterates MacroGenics stock rating ahead of ESMO data

Citizens has reiterated a Market Perform rating on MacroGenics Inc. (NASDAQ:MGNX) ahead of the ESMO 2026 conference, where MacroGenics will present data for its MGC026 antibody-drug conjugate and lorigerlimab LINNET study. The firm notes that MacroGenics shares are currently trading at a significant discount …

Genie Energy Ltd. Class B Revenue Breakdown – DUS:6GE

Genie Energy Ltd. Class B (DUS:6GE) generated 427.41 million EUR in revenue last year, with its Genie Retail Energy segment contributing the most at 407.36 million EUR. The majority of this revenue, 427.26 million EUR, originated from the United States market. These figures represent …

ABS Direct Equity Fund LLC Takes Position in Genius Sports Limited $GENI

ABS Direct Equity Fund LLC has acquired 400,000 shares of Genius Sports Limited ($GENI) in the first quarter, valued at approximately $1.77 million, making it a significant holding in their portfolio. Genius Sports reported higher-than-expected revenue but missed EPS estimates, leading to continued negative …

Soligenix Inc (SNGX) Institutional Confidence

This article provides an overview of Soligenix Inc.'s (SNGX) institutional confidence, highlighting its TradingKey Stock Score and institutional shareholder activity. The data shows key institutional holders, their share counts, and the percentage change in their holdings, with Intracoastal Capital, L.L.C., and DRW Securities, LLC …

Genius Sports Ltd (GENI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Genius Sports Ltd (GENI), categorizing its income by business segments and geographical regions. It highlights that the Betting, Technology, Content, and Service segment is the largest contributor, followed by Media Technology, Content, and Service, and then …

Genius Sports (NYSE:GENI) Downgraded to Strong Sell Rating by Wall Street Zen

Genius Sports (NYSE:GENI) has been downgraded from a "sell" to a "strong sell" rating by Wall Street Zen, despite a broader analyst consensus of "Moderate Buy" with an average price target of $11.56. The company reported better-than-expected revenue of $187.95 million last quarter but …

SNGX|Soligenix Inc|Price:0.371|Chg%:-0.002

Soligenix Inc (SNGX) is trading at $0.371, reflecting a slight decrease of 0.41%. Despite recent market performance, its fundamentals are considered healthy with high growth potential, and it is currently rated as "Buy" by analysts with a target price of $1.75. The company specializes …

Genius Sports Limited Revenue Breakdown – NYSE:GENI

Genius Sports Limited (NYSE: GENI) generated $669.49 million USD in revenue last year. The "Betting Technology, Content and Services" segment was the top performer, contributing $471.53 million USD, while the United States was the largest geographical contributor with $274.49 million USD in revenue.

Genie Energy Ltd (GNE) Income Statement

MacroGenics Inc (MGNX) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for MacroGenics Inc (MGNX), allowing users to evaluate the company's financial health and stability. It includes data on operating, investing, and financing cash flows, along with a definition and explanation of each cash …

Genius Sports Limited $GENI Shares Bought by Senvest Management LLC

Senvest Management LLC significantly increased its stake in Genius Sports Limited (NYSE:GENI) during the first quarter of 2026, boosting its holdings by 45.1% to 13.65 million shares, representing 5.54% of the company. Other institutional investors like Wellington Management and Voss Capital also increased their …

Granahan Investment Management LLC Reduces Position in Genius Sports Limited $GENI

Granahan Investment Management LLC reduced its stake in Genius Sports Limited ($GENI) by 31.5% in the first quarter, now holding 5.38 million shares valued at $23.85 million. Despite this, analyst sentiment remains "Moderate Buy" with a consensus price target of $11.56, while the company …

Soligenix, Inc. Revenue Breakdown – NASDAQ:SNGX

This article provides financial information for Soligenix, Inc. (NASDAQ: SNGX) available on TradingView. It highlights that the market was closed with no trades and points to various financial data points like overview, statements, statistics, dividends, and earnings. The article also mentions top segments and …

Soligenix Inc (SNGX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Soligenix Inc (SNGX), noting its current valuation score of 6.65, which ranks 310 out of 386 in the Biotechnology & Medical Research industry. The company's P/E ratio is -0.26, and other key financial metrics like P/B, P/S, …

TradingKey

This page provides an income statement for MacroGenics Inc (MGNX), detailing its quarterly and annual financial performance. It includes metrics like total revenue, operating expenses, net income, and earnings per share, along with year-over-year comparisons. The data allows investors to analyze the company's operational …

MacroGenics Inc (MGNX) Institutional Confidence

MacroGenics Inc (MGNX) currently holds an institutional shareholding score of 5.00, placing it 132nd out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 68.70%, marking a 14.58% increase quarter-over-quarter. James Simons is the largest institutional shareholder.

MacroGenics slips on trial data for lead asset (MGNX:NASDAQ)

MacroGenics (MGNX) shares fell by nearly 6% following the release of updated results from an ongoing Phase 1 trial for its lead asset, MGC026. The drug, an antibody-based therapy, is being developed to target solid tumors. The trial data involved 74 patients.

Ingenia Communities (ASX:INA) Retreats as Market Focus Turns to Property Valuations and Growth

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

MacroGenics, Inc. announced a clinical update on its ongoing Phase 1 study for MGC026, a B7-H3-directed antibody-drug conjugate (ADC), for advanced solid tumors. Interim results, showing the achievement of a pre-specified response threshold in squamous cell carcinoma of the head and neck, will be …

MGNX stock holds focus as MacroGenics plans and pipeline metrics matter

MacroGenics (MGNX) is a small-cap biotech company whose stock performance is heavily influenced by pipeline execution, balance sheet health, and financial metrics like revenue and cash use. Investors should focus on the company's reported numbers, program milestones, and clinical data readouts rather than broad …

Genius Sports Buys Second Spectrum for $200M

Genius Sports, a data and technology firm working with sports leagues and sportsbooks, has acquired Second Spectrum for $200 million. Second Spectrum specializes in real-time video data collection and analysis for major sports leagues and media providers, addressing a gap in Genius's existing services. …

MacroGenics’ MGC026 meets trial threshold in head and neck cancer

MacroGenics Inc. announced that its Phase 1 study for MGC026, an antibody-drug conjugate, met the pre-specified response threshold in the head and neck cancer cohort, allowing it to advance to Stage 2 enrollment. Interim results from the study, which has enrolled 74 patients, will …

Stifel Maintains Genius Sports(GENI.US) With Hold Rating, Raises Target Price to $7

Stifel has reiterated its Hold rating on Genius Sports (GENI.US) while increasing its price target to $7. This adjustment suggests an updated valuation by the firm for the sports data and technology company.

ETFs Investing in Genius Sports Limited Stocks

This article lists various ETFs that hold Genius Sports Limited (GENI) stock. It provides a detailed table including each ETF's market value, weight of GENI stock, issuer, management style, expense ratio, AUM, price, and performance metrics. The information aims to help investors find ETFs …

Genie Energy will post results before its 8:30 a.m. call